Cabio Biotech Wuhan Co Ltd Net Asset Quality Index
Cabio Biotech Wuhan Co Ltd net asset quality index. Cabio Biotech Wuhan Co Ltd (688089) has a Net Asset Quality Index of 89.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.82 Billion minus total liabilities of CN¥183.42 Million yields net assets of CN¥1.64 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See what is Cabio Biotech Wuhan Co Ltd's book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Cabio Biotech Wuhan Co Ltd (2013–2024)
Net asset quality index of Cabio Biotech Wuhan Co Ltd from 2013 to 2024. This chart shows how Cabio Biotech Wuhan Co Ltd's Net Asset Quality Index has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the index stands at 89.9%, representing net assets of CN¥1.64 Billion against total assets of CN¥1.82 Billion CNY. Check Cabio Biotech Wuhan Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Cabio Biotech Wuhan Co Ltd Net Asset Quality Index by Year (2013–2024)
Cabio Biotech Wuhan Co Ltd net asset quality index by year from 2013 to 2024. The table below presents the year-by-year Net Asset Quality Index for Cabio Biotech Wuhan Co Ltd from 2013 to 2024, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 688089 market cap overview.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 93.0% | CN¥1.57 Billion | CN¥1.69 Billion | CN¥117.27 Million | ▲ +0.3 pp |
| 2023 | 92.7% | CN¥1.49 Billion | CN¥1.61 Billion | CN¥117.60 Million | ▲ +4.2 pp |
| 2022 | 88.5% | CN¥1.43 Billion | CN¥1.61 Billion | CN¥185.77 Million | ▼ -6.9 pp |
| 2021 | 95.4% | CN¥1.38 Billion | CN¥1.45 Billion | CN¥66.68 Million | ▼ -0.3 pp |
| 2020 | 95.7% | CN¥1.32 Billion | CN¥1.38 Billion | CN¥59.30 Million | ▼ -0.6 pp |
| 2019 | 96.3% | CN¥1.25 Billion | CN¥1.30 Billion | CN¥48.26 Million | ▲ +5.7 pp |
| 2018 | 90.5% | CN¥526.20 Million | CN¥581.19 Million | CN¥54.99 Million | ▼ -1.2 pp |
| 2017 | 91.7% | CN¥464.39 Million | CN¥506.37 Million | CN¥41.98 Million | ▲ +7.3 pp |
| 2016 | 84.4% | CN¥402.60 Million | CN¥476.78 Million | CN¥74.17 Million | ▲ +3.9 pp |
| 2015 | 80.6% | CN¥354.83 Million | CN¥440.43 Million | CN¥85.60 Million | ▼ -11.3 pp |
| 2014 | 91.8% | CN¥465.90 Million | CN¥507.41 Million | CN¥41.52 Million | ▲ +0.3 pp |
| 2013 | 91.5% | CN¥428.24 Million | CN¥467.92 Million | CN¥39.68 Million | — |